ArticleAdvances in therapy2026
Hourly Blood Urea Nitrogen Trajectories and ICU Mortality Risk in Critically Ill Patients with Gastrointestinal Bleeding: A Multicenter Retrospective Cohort Study.
Article in Advances in therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionElevated blood urea nitrogen (BUN) is associated with adverse outcomes in gastrointestinal bleeding (GIB), but isolated measurements may not capture early temporal patterns.
methodsA multicenter retrospective cohort study included 5847 adult patients with GIB from four databases (2008-2022). Serial BUN measurements during the first 24 h after ICU admission were mapped to hourly intervals, with at least 12 observed values required. Generalized additive models assessed concentration-duration patterns, adjusted logistic regression evaluated 15 BUN ranges, and restricted cubic splines examined time-weighted BUN. Meta-analysis, measurement-density sensitivity analyses, and static-dynamic model comparisons were performed.
resultsMale and female patients comprised 56.5-58.7% and 41.3-43.5% of each cohort,, respectively. ICU mortality ranged from 18.0% to 19.7%. BUN < 30 mg/dL sustained for > 12 h lowered mortality odds (OR: 0.40-0.62), while BUN ≥ 50 mg/dL for >18 h markedly increased them (OR: 1.55-3.39). Prolonged time within 5-30 mg/dL was associated with lower mortality odds, while greater exposure to 40-70 mg/dL increased risk, with no detectable between-database heterogeneity. Associations were nonlinear and remained broadly consistent in denser-measurement subsets. Dynamic models improved AUC from 0.678-0.701 to 0.718-0.748 (all DeLong P ≤ 0.05), with improved reclassification and lower Brier scores.
conclusionEarly dynamic BUN trajectories were associated with ICU mortality and provided incremental prognostic information beyond admission BUN alone. Incorporating both the magnitude and persistence of BUN abnormalities may support early risk stratification in critically ill patients with GIB.
Indexed as
Identifiers
42831954What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.